Hong Yuan Holding Group
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HGYN research report →
Price Chart
About the company
Hong Yuan Holding Group presently conducts no substantial business operations. Historically, the company's primary focus lay in the advancement and commercialization of bio-derived resins. It operated under the name Cereplast, Inc.
- CEO
- Xudong Li
- IPO
- 2005
- Employees
- 10
- HQ
- Zhengzhou, SI, CN
Get TickerSpark's AI analysis on HGYN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.73M
- P/E
- 166.67
- PEG
- 0.27
- P/S
- 5.83
- P/B
- -24.48
- EV/EBITDA
- 82.63
- Div Yield
- 0.00%
- Gross Margin
- 69.48%
- Op Margin
- 6.52%
- Net Margin
- 3.82%
- ROE
- -20.00%
- ROIC
- -48.26%
Latest fiscal year · YoY change
- Revenue
- $837.75K+241.1%
- Gross Profit
- $539.64K+480.9%
- Op Income
- $176.48K
- Net Income
- $158.14K+260.0%
- EPS
- $0.00+261.5%
- OCF Growth
- +70.5%
- FCF Growth
- +70.5%
- 52W High
- $0.24
- 52W Low
- $0.00
- 50D MA
- $0.03
- 200D MA
- $0.06
- Beta
- 3.81
- RSI (14)
- 63
- Avg Volume
- 16.29K
No earnings-call transcripts are available for HGYN yet.
- Free Float
- 33.0%
- Shares Outstanding
- 74.64M
- Float Shares
- 24.64M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 2, 11 | SCHEER FREDERIC | buy | 12,841 |
| Dec 31, 10 | McMURRAY MARGARET | other | 0 |
| Dec 31, 10 | McMURRAY MARGARET | other | 0 |
| Dec 31, 10 | McMURRAY MARGARET | other | 0 |
| Dec 31, 10 | McMURRAY MARGARET | other | 0 |
| Dec 31, 10 | McMURRAY MARGARET | other | 0 |
| Dec 31, 10 | McMURRAY MARGARET | other | 0 |
| Dec 31, 10 | McMURRAY MARGARET | other | 0 |
| Dec 31, 10 | LARRIVEE GARY | other | 0 |
| Dec 31, 10 | LARRIVEE GARY | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HGYN coverage
Recent articles, reports, and earnings notes.
No research on HGYN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HGYN report →